Noninfectious Uveitis
Showing 1 - 25 of 347
Uveitis Posterior Non-Infectious, Uveitis, Intermediate, Noninfectious Panuveitis Trial in Waltham, Erie (ESK-001)
Recruiting
- Uveitis Posterior Non-Infectious
- +2 more
-
Waltham, Massachusetts
- +1 more
Jul 18, 2023
Noninfectious Uveitis Trial in Worldwide (Filgotinib, Placebo to match filgotinib, Prednisone)
Uveitis, Intermediate Uveitis, Posterior Uveitis Trial in Chicago, Omaha, Cleveland (triamcinolone acetonide (Triesence®))
Completed
- Uveitis
- +4 more
- triamcinolone acetonide (Triesence®)
-
Chicago, Illinois
- +2 more
Feb 17, 2021
Uveitis, Posterior, Uveitis, Intermediate, Panuveitis Trial in United States (Acthar Gel)
Terminated
- Uveitis, Posterior
- +2 more
- Acthar Gel
-
Clearwater, Florida
- +7 more
Jul 12, 2021
Pediatric Uveitis Patients
Not yet recruiting
- Uveitis
-
Assiut, Egypt
- +1 more
Oct 1, 2023
Non-infectious Uveitis Trial (care strategy)
Not yet recruiting
- Non-infectious Uveitis
- care strategy
- (no location specified)
Jun 26, 2023
The Cohort Study of Uveitis Patients
Not yet recruiting
- Uveitis
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Feb 3, 2023
Uveitis With Biologic Drugs in Resistant Cases
Not yet recruiting
- Uveitis
- Biologic drugs
- (no location specified)
Apr 21, 2022
Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in Plano (Yutiq 0.18 MG Drug Implant, Sham Injection)
Not yet recruiting
- Uveitis
- +3 more
- Yutiq 0.18 MG Drug Implant
- Sham Injection
-
Plano, TexasTexas Retina Associates
Aug 3, 2022
Intra and Extra Intestinal Microbiome in Non-infectious Uveitis
Unknown status
- Autoimmune Uveitis
- +7 more
-
Jakarta Pusat, Jakarta, IndonesiaRSUPN dr. Cipto Mangunkusumo (Cipto Mangunkusumo Hospital)
Oct 15, 2019
Uveitis, JIA Trial in Australia, United Kingdom, United States (Adalimumab, Placebo)
Recruiting
- Uveitis
- JIA
- Adalimumab
- Placebo
-
Sacramento, California
- +24 more
Mar 9, 2022
Uveitis Trial in United States (Izokibep, Prednisone/Prednisolone)
Active, not recruiting
- Uveitis
-
Los Angeles, California
- +3 more
Jul 18, 2022
Diabetic Retinopathy, Vitreomacular Traction Trial in Minya (Methotrexate 25 MG/ML, parsplana vitrectomy)
Recruiting
- Diabetic Retinopathy
- Vitreomacular Traction
- Methotrexate 25 MG/ML
- parsplana vitrectomy
-
Minya, Minia, Egyptophthalmology department, Minia university hospital
Sep 8, 2023
Uveitis Trial (Adalimumab plus different doses of oral glucocorticosteroid)
Not yet recruiting
- Uveitis
- Adalimumab plus different doses of oral glucocorticosteroid
- (no location specified)
Nov 1, 2021
Corticosteroid Combining Noncorticosteroid Systemic
Recruiting
- Vogt Koyanagi Harada Disease (VKH)
- noncorticosteroid systemic immunomodulatory therapy (NCSIT)
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Nov 3, 2021
Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in United States (4 mg CLS-TA Suprachoriodal Injection)
Completed
- Uveitis
- +4 more
- 4 mg CLS-TA Suprachoriodal Injection
-
Phoenix, Arizona
- +9 more
Jun 18, 2021
Non-infectious Uveitis Trial in Cleveland, Arlington, Houston (EYS606)
Completed
- Non-infectious Uveitis
- EYS606
-
Cleveland, Ohio
- +2 more
Mar 9, 2022
Macular Edema Trial in United States (Updated Dexamethasone Posterior Segment Drug Delivery System, Approved Dexamethasone
Completed
- Macular Edema
- Updated Dexamethasone Posterior Segment Drug Delivery System
- Approved Dexamethasone Posterior Segment Drug Delivery System
-
Glendale, California
- +6 more
Feb 11, 2022
Uveitis, Macular Edema, Uveitis, Posterior Trial in United States (4 mg CLS-TA, 0.8 mg CLS-TA)
Completed
- Uveitis
- +5 more
- 4 mg CLS-TA
- 0.8 mg CLS-TA
-
Miami, Florida
- +10 more
Jan 18, 2021
Uveitis Trial run by the NEI (B27PD, Placebo)
Completed
- Uveitis
- B27PD
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 13, 2018
Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome Trial in Worldwide (No intervention is foreseen by
Recruiting
- Hereditary Autoinflammatory Diseases
- +7 more
- No intervention is foreseen by the protocol.
-
Bethesda, Maryland
- +99 more
Jan 6, 2022
Eye Diseases, Uveitis Trial in Leuven (Abatacept 125 MG/ML Prefilled Syringe)
Active, not recruiting
- Eye Diseases
- Uveitis
- Abatacept 125 MG/ML Prefilled Syringe
-
Leuven, Vlaams-Brabant, BelgiumUZLeuven
Jan 26, 2023